S100A6 and intrahepatic cholangiocarcinoma: S100A6 was shown to promote the proliferation of intrahepatic cholangiocarcinoma cells and of cervical cells via activating the p38/MAPK (Zheng et al., 2017) and PI3K/Akt pathways (Li et al., 2018), respectively.